1.Association of serum BDNF concentration with high-intensity interval training
Koichiro Azuma ; Yusuke Osawa ; Shogo Tabata ; Shiori Horisawa ; Fuminori Katsukawa ; Hiroyuki Ishida ; Yuko Oguma ; Toshihide Kawai ; Shuji Oguchi ; Atsumi Ota ; Haruhito Kikuchi ; Mitsuru Murata ; Hideo Matsumoto
Japanese Journal of Physical Fitness and Sports Medicine 2015;64(2):227-232
To evaluate the association of serum BDNF concentration with high-intensity interval training, 12 healthy male volunteers, aged 28-48 years, completed 16-week high-intensity interval training (HIIT) using ergometer. Training program consisted of >90% VO2 peak for 60 sec separated by 60 sec active rest period for 8-12 sets twice weekly for 16-week. Maximal exercise tolerance tests were performed before (0-week), 4-week, and 16-week after the intervention program. VO2 peak as well as peak watt was linearly increased after 4-week (9% for both VO2 peak and peak watt) and 16-week HIIT training (15% for VO2 peak and 18% for peak watt, p<0.01). However, there was no change in serum BDNF concentration by HIIT. On the other hand, there was a positive association of serum BDNF concentration at baseline with % increase in peak watt after the intervention (ρ=0.60, p<0.05). The association between BDNF and exercise training is still unclear, and more studies are needed to clarify the above positive association.
2.Survey of Fall Rates in Classification of Hypnotics
Haruka YAGI ; Yoshitaka YAMAMOTO ; Ippei USUKUBO ; Yuka YUKA ; Asako SHIMOYAMA ; Shuji AZUMA ; Hirokazu TABATA ; Yasuhiro INAGAKI ; Ryuji KOTERA ; Akio SHIBANAMI
Journal of the Japanese Association of Rural Medicine 2019;68(4):490-495
Hospitalized patients often have insomnia, and in many cases it is necessary to administer hypnotics. Although the hypnotics currently used in Japan are mainly benzodiazepine receptor agonists, there is an associated risk of falling due to muscle relaxant action, and carryover effect. It is believed that orexin receptor antagonists, which have a different mechanism of action from conventional hypnotics, have no muscle relaxant action and are thus considered to be much safer. Therefore, in this study we compared fall rate according to the class of hypnotics that the patient had been taking. We analyzed hospitalized patients taking orexin receptor antagonists (ORB), benzodiazepines (BZDs), and non-BZDs, who had falls and were treated in our hospital from April 1, 2017 to December 31, 2017. Patients were grouped according to the drug they were taking before the fall occurred and the fall rate was calculated and compared. The total number of falls in the target patients was 45, and the total number of people prescribed hypnotics in the study period was 1682. Fall rate by classification of hypnotics was the lowest in the ORB group at 1.45%, which was significantly lower than that of the BZD group, suggesting the possibility that ORBs have minimal influence on falls. In addition, the fall rate in the non-BZD group was significantly lower than that of the BZD group.